Eli Lilly and Company
LLY-
Point Biopharma Inc soared 84% to $12.23 after the company agreed to be acquired by Eli Lilly for $12.50 a share in cash or $1.4 billion.
Eli Lilly & Company decreased 1.1% to $532.39.
Oct 3, 2023
|
|
| |
|
| Trading Volume | 58,448 |
|
|
955.07 - 525.10 |
| Market Cap Full | $ 892.8B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.3% | 33.2% | -6.2% | 3.7% |
| Q2 | - | 19.5% | 36.4% | 13.2% |
| Q3 | - | 16.3% | 14.6% | -0.6% |
| Q4 | - | -0.4% | 8.5% | 13.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 10.5 | 16.8 | 3.2 | -6.7 | 13.1 | 10.9 | -11.1 | 16.3 | - | - | - | -2.8 |
| 2023 | |||||||||||
| -5.9 | -9.6 | 10.4 | 15.3 | 8.4 | 9.1 | -3 | 21.9 | -3.1 | 3.1 | 6.8 | -1.3 |
| 2022 | |||||||||||
| -11.8 | 2.6 | 14.6 | 2 | 7.3 | 3.4 | 1.7 | -8.6 | 7 | 12 | 2.8 | -1.4 |
| 2021 | |||||||||||
| 24.7 | -1.1 | -9.6 | -1.6 | 9.7 | 14.5 | 6.4 | 5.8 | -10.6 | 10.3 | -2.6 | 11.4 |
| 2020 | |||||||||||
| 7 | -11.8 | 12.2 | 11.5 | -1.1 | 7.3 | -8.5 | -1.2 | -1.7 | -10.6 | 11.6 | 14.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 1.5 | 2.1 | 1.5 | 1.6 |
| Q2 | 2 | 1.1 | 1.5 | 1.6 |
| Q3 | -0.1 | 1.6 | 1.2 | 1.3 |
| Q4 | 0 | 2.1 | 1.9 | 2.3 |
| A | 3.38 | 6.9 | 6.1 | 6.8 |